Skip to main content

Posts Tagged ‘Biomarkers’

First-Ever Rankings: Top 25 Companies In Precision Medicine

  Thanks to one of my LinkedIn contacts, I was introduced to a newly released “scorecard” that ranks pharmaceutical and biotechnology companies based on their precision medicine efforts. In essence, the organizations who made the cut are the ones moving precision medicine forward. They’re the ones focused on leveraging biomarkers to develop new therapies. 

Companion Diagnostics and Pharmaceuticals: Tying The Knot

  I recently read an article, The Future of Cancer Treatment Is (Almost) Here, which discusses liquid biopsy, a method of using blood samples to detect cancer. While new forms of cancer detection and monitoring continue to be developed, we’ve already made significant strides in the treatment of certain diseases. 

Living In A Personalized World: Drug Dosing And Safety

  Dr. Janet Woodcock, the director of the Center for Drug Evaluation and Research (CDER) at the FDA, recently posted a blog piece that discussed the department’s strides in precision and personalized medicine. She points out that since 2012, CDER has approved 30 targeted therapies, eight of which were in 2014.